RU2678571C1 - Терапевтическое и/или профилактическое средство, содержащее производное 1-индансульфамида, против боли - Google Patents

Терапевтическое и/или профилактическое средство, содержащее производное 1-индансульфамида, против боли Download PDF

Info

Publication number
RU2678571C1
RU2678571C1 RU2016122189A RU2016122189A RU2678571C1 RU 2678571 C1 RU2678571 C1 RU 2678571C1 RU 2016122189 A RU2016122189 A RU 2016122189A RU 2016122189 A RU2016122189 A RU 2016122189A RU 2678571 C1 RU2678571 C1 RU 2678571C1
Authority
RU
Russia
Prior art keywords
pain
mmol
dihydro
sulfamide
therapeutic
Prior art date
Application number
RU2016122189A
Other languages
English (en)
Russian (ru)
Other versions
RU2016122189A (ru
Inventor
Хироюки ХИГАСИЯМА
Юдзи КАДЗУТА
Кеисуке ХАСИМОТО
Original Assignee
Эйсай Ар Энд Ди Менеджмент Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эйсай Ар Энд Ди Менеджмент Ко., Лтд. filed Critical Эйсай Ар Энд Ди Менеджмент Ко., Лтд.
Publication of RU2016122189A publication Critical patent/RU2016122189A/ru
Application granted granted Critical
Publication of RU2678571C1 publication Critical patent/RU2678571C1/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
RU2016122189A 2013-12-19 2014-12-17 Терапевтическое и/или профилактическое средство, содержащее производное 1-индансульфамида, против боли RU2678571C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013-262743 2013-12-19
JP2013262743 2013-12-19
PCT/JP2014/083374 WO2015093515A1 (ja) 2013-12-19 2014-12-17 １－インダンスルファミド誘導体を含む疼痛の治療および／または予防剤

Publications (2)

Publication Number Publication Date
RU2016122189A RU2016122189A (ru) 2018-01-24
RU2678571C1 true RU2678571C1 (ru) 2019-01-30

Family

ID=53402860

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016122189A RU2678571C1 (ru) 2013-12-19 2014-12-17 Терапевтическое и/или профилактическое средство, содержащее производное 1-индансульфамида, против боли

Country Status (14)

Country Link
US (1) US9610262B2 (https=)
EP (1) EP3085369B1 (https=)
JP (1) JP6518595B2 (https=)
KR (1) KR102250214B1 (https=)
CN (1) CN105792821B (https=)
AU (1) AU2014367781B2 (https=)
BR (1) BR112016012833B1 (https=)
CA (1) CA2932529C (https=)
ES (1) ES2673876T3 (https=)
IL (1) IL246036B (https=)
MX (1) MX370898B (https=)
RU (1) RU2678571C1 (https=)
SG (1) SG11201604484UA (https=)
WO (1) WO2015093515A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200132858A (ko) * 2018-03-20 2020-11-25 에자이 알앤드디 매니지먼트 가부시키가이샤 간질 치료제
TW202345782A (zh) * 2022-04-27 2023-12-01 日商衛材R&D企管股份有限公司 帕金森氏症治療用醫藥組成物
KR102815521B1 (ko) 2022-11-11 2025-06-04 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR102803991B1 (ko) 2022-11-11 2025-05-13 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR102815520B1 (ko) 2022-11-11 2025-06-04 덕산에테르씨티 주식회사 내화성능 및 강도가 보강된 압력용기
KR102917062B1 (ko) 2023-11-01 2026-02-05 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버
KR102917063B1 (ko) 2023-11-01 2026-02-23 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버
KR102917061B1 (ko) 2023-11-01 2026-02-05 덕산에테르씨티 주식회사 압력 용기의 숄더부 보호용 커버

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075752A1 (en) * 2005-12-19 2007-07-05 Janssen Pharmaceutica N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070191452A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
US20080096903A1 (en) * 2006-10-19 2008-04-24 Wyeth Sulfamoyl-containing derivatives and uses thereof
RU2012110908A (ru) * 2012-03-22 2013-09-27 Общество с ограниченной ответственностью "Биофармокс" Синтетические пептиды с ненаркотическим типом анальгетического действия

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI433674B (zh) 2006-12-28 2014-04-11 Infinity Discovery Inc 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類
EP2417101B1 (en) * 2009-04-09 2013-10-23 Merck Sharp & Dohme B.V. Indane derivatives
TW201217312A (en) 2010-09-22 2012-05-01 Gruenenthal Gmbh Substituted benzamide compounds
MY169073A (en) * 2012-06-21 2019-02-13 Eisai R&D Man Co Ltd Indanesulfamide derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007075752A1 (en) * 2005-12-19 2007-07-05 Janssen Pharmaceutica N.V. Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
US20070191452A1 (en) * 2006-02-15 2007-08-16 Smith-Swintosky Virginia L Use of benzo-heteroaryl sulfamide derivatives for the treatment of pain
US20080096903A1 (en) * 2006-10-19 2008-04-24 Wyeth Sulfamoyl-containing derivatives and uses thereof
RU2012110908A (ru) * 2012-03-22 2013-09-27 Общество с ограниченной ответственностью "Биофармокс" Синтетические пептиды с ненаркотическим типом анальгетического действия

Also Published As

Publication number Publication date
IL246036B (en) 2018-11-29
AU2014367781B2 (en) 2019-07-04
JPWO2015093515A1 (ja) 2017-03-23
EP3085369B1 (en) 2018-04-04
KR102250214B1 (ko) 2021-05-07
EP3085369A1 (en) 2016-10-26
US9610262B2 (en) 2017-04-04
WO2015093515A1 (ja) 2015-06-25
SG11201604484UA (en) 2016-07-28
ES2673876T3 (es) 2018-06-26
EP3085369A4 (en) 2017-05-10
RU2016122189A (ru) 2018-01-24
CN105792821A (zh) 2016-07-20
CA2932529A1 (en) 2015-06-25
US20160303058A1 (en) 2016-10-20
JP6518595B2 (ja) 2019-05-22
IL246036A0 (en) 2016-07-31
BR112016012833B1 (pt) 2022-11-16
BR112016012833A2 (https=) 2017-08-08
AU2014367781A1 (en) 2016-06-23
CA2932529C (en) 2022-03-22
CN105792821B (zh) 2018-05-04
MX370898B (es) 2020-01-09
KR20160106053A (ko) 2016-09-09
MX2016007370A (es) 2016-10-03

Similar Documents

Publication Publication Date Title
RU2678571C1 (ru) Терапевтическое и/или профилактическое средство, содержащее производное 1-индансульфамида, против боли
CN110088107B (zh) 化合物、组合物及其用途
RU2619937C2 (ru) Новое индансульфамидное производное
AU2021215274B2 (en) Targeted drug rescue with novel compositions, combinations, and methods thereof
AU2002237654B2 (en) Piperazine derivatives, their preparation and their use for treating central nervous system (CNS) disorders
JP2001516718A (ja) ５−ＨＴ再取り込み阻害剤およびｈ５−ＨＴ１Ｂアンタゴニストまたは部分的アゴニストの組み合わせ
KR20240158951A (ko) 결정질 아티카프란트의 순수한 형태
CA2872324C (en) Metabolites of (1r-trans)-n-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]propanamide
EP3201178B1 (en) Arylalkylpiperazines for use as neuroprotective agents
KR20190065246A (ko) 화합물 및 조성물 및 이들의 용도
JP2021073171A (ja) （ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物
Andrés et al. Synthesis of 3a, 4-dihydro-3H-[1] benzopyrano [4, 3-c] isoxazoles, displaying combined 5-HT uptake inhibiting and α2-adrenoceptor antagonistic activities: a novel series of potential antidepressants
JPWO2005079845A1 (ja) 片頭痛予防薬
EP4190770A1 (en) Dual regulator for mglur5 and 5-ht2a receptors and use thereof
EP2694519A1 (en) Novel heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
TWI387455B (zh) 苯并-稠合的雜環磺醯胺衍生物用於治療疼痛之用途
CA2736559A1 (en) Novel pharmaceutical composition for treating nociceptive pain
JPH06100509A (ja) シクロペンテノン化合物及び該化合物を有効成分とする脳機能改善薬